Holen Sie sich die Stockscreener-App
23.96
1.48%
-0.36
Vorhandelsmarkt:
24.19
0.23
+0.96%
Schlusskurs vom Vortag:
$24.32
Offen:
$24.22
24-Stunden-Volumen:
14,793
Relative Volume:
0.57
Marktkapitalisierung:
$294.16M
Einnahmen:
$9.71M
Nettoeinkommen (Verlust:
$-29.96M
KGV:
-6.8851
EPS:
-3.48
Netto-Cashflow:
$-14.79M
1W Leistung:
-2.64%
1M Leistung:
+23.25%
6M Leistung:
-22.76%
1J Leistung:
-3.31%
1-Tages-Spanne:
$23.49
$24.93
1-Wochen-Bereich:
$22.79
$25.10
52-Wochen-Spanne:
$18.35
$35.00
Xoma Royalty Corp Stock (XOMA) Company Profile
Firmenname
Xoma Royalty Corp
Sektor
Branche
Telefon
510-204-7239
Adresse
2200 POWELL STREET, EMERYVILLE, CA
Vergleichen Sie XOMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
23.96 | 294.16M | 9.71M | -29.96M | -14.79M | -3.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-17 | Eingeleitet | The Benchmark Company | Buy |
| 2024-04-29 | Eingeleitet | Leerink Partners | Outperform |
| 2021-09-07 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-06-29 | Eingeleitet | Aegis Capital | Buy |
| 2021-01-19 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-18 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-17 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-09-05 | Hochstufung | Wedbush | Neutral → Outperform |
| 2017-06-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-14 | Herabstufung | Wedbush | Outperform → Neutral |
| 2016-03-11 | Bestätigt | Wedbush | Outperform |
| 2015-07-23 | Herabstufung | Jefferies | Buy → Hold |
| 2015-07-22 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | Fortgesetzt | ROTH Capital | Buy |
| 2014-04-29 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-11 | Herabstufung | MLV & Co | Buy → Hold |
| 2014-03-05 | Bestätigt | Ladenburg Thalmann | Buy |
| 2013-10-31 | Bestätigt | MLV & Co | Buy |
| 2013-05-09 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-05-14 | Eingeleitet | Cowen & Co | Outperform |
| 2011-03-31 | Bestätigt | MLV Capital | Buy |
| 2011-03-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2011-01-06 | Bestätigt | Ladenburg Thalmann | Buy |
| 2011-01-04 | Bestätigt | Wedbush | Outperform |
Alle ansehen
Xoma Royalty Corp Aktie (XOMA) Neueste Nachrichten
XOMA Royalty Corp expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Renaissance Technologies LLC Buys 7,619 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
JPMorgan Chase & Co. Raises Stake in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMAP) Short Interest Update - Defense World
XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by Geode Capital Management LLC - Defense World
Benchmark Begins Coverage on XOMA (NASDAQ:XOMA) - Defense World
Benchmark Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq
Benchmark Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq
XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World
Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals
Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals
XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability - Yahoo
XOMA completes sale of Kinnate assets for up to $270 million - Investing.com Australia
Xoma Royalty Completes Sale Of Kinnate Pipeline Assets - MarketScreener
XOMA Royalty Completes Sale of Kinnate Pipeline Assets - The Manila Times
XOMA Co. (NASDAQ:XOMA) Director Joseph M. Limber Buys 17,935 Shares - MarketBeat
XOMA (NASDAQ:XOMA) Stock Rating Upgraded by StockNews.com - Defense World
XOMA Royalty Corp's chief investment officer purchases $49,400 in depositary shares By Investing.com - Investing.com India
XOMA Royalty Corp’s chief investment officer purchases $49,400 in depositary shares By Investing.com - Investing.com Canada
CIO’s Bold Move: A Major Investment in Xoma Stock - TipRanks
XOMA Royalty Corp Officer Acquires Additional Shares - TradingView
XOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
20 Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist - Seeking Alpha
Director Makes Bold Move with Major Xoma Stock Purchase - TipRanks
XOMA stock touches 52-week low at $18.59 amid market shifts - Investing.com Australia
XOMA stock touches 52-week low at $18.59 amid market shifts By Investing.com - Investing.com South Africa
Xoma royalty director Joseph Limber purchases shares worth $760,144 By Investing.com - Investing.com South Africa
Xoma royalty director Joseph Limber purchases shares worth $760,144 - Investing.com
XOMA (NASDAQ:XOMA) Rating Lowered to Sell at StockNews.com - Defense World
Top Executives Make Significant Moves in Xoma Stock! - TipRanks
Xoma royalty corp CFO buys $25k in depositary shares By Investing.com - Investing.com Canada
XOMA Royalty Corp’s chief investment officer acquires $26,200 in shares By Investing.com - Investing.com India
Xoma royalty corp CFO buys $25k in depositary shares - Investing.com
XOMA Royalty Corp Executives Increase Their Holdings - TradingView
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference - The Manila Times
Key Investment Insights: XOMA CIO Takes Stage at Major Healthcare Conference - Stock Titan
Charles Schwab Investment Management Inc. Grows Stock Position in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA stock touches 52-week low at $19.9 amid market shifts - Investing.com India
HC Wainwright Reiterates Buy Rating for XOMA (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMAO) Sees Significant Growth in Short Interest - The AM Reporter
H.C. Wainwright maintains Buy rating on XOMA with $104 target By Investing.com - Investing.com South Africa
The Analyst Verdict: XOMA Royalty In The Eyes Of 4 Experts - Benzinga
H.C. Wainwright maintains Buy rating on XOMA with $104 target - Investing.com
XOMA Co. (NASDAQ:XOMAO) Short Interest Up 110.7% in March - Defense World
Finanzdaten der Xoma Royalty Corp-Aktie (XOMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
3.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):